...
首页> 外文期刊>Diagnostic cytopathology >Fine-needle aspiration of follicular patterned lesions of the thyroid: Diagnosis, management, and follow-up according to National Cancer Institute (NCI) recommendations.
【24h】

Fine-needle aspiration of follicular patterned lesions of the thyroid: Diagnosis, management, and follow-up according to National Cancer Institute (NCI) recommendations.

机译:甲状腺滤泡样病变的细针穿刺:根据国家癌症研究所(NCI)的建议进行诊断,处理和随访。

获取原文
获取原文并翻译 | 示例
           

摘要

The National Cancer Institute (NCI) State of the Science Conference on thyroid fine-needle aspiration (FNA) proposed that follicular patterned lesions can be divided into two diagnostic categories; follicular lesion of undetermined significance/Atypia of undetermined significance (FLUS/AUS) and suspicious for follicular neoplasm/follicular neoplasm (SFON/FON). The former group can benefit from repeat FNA (RFNA) to achieve a more definitive diagnosis and the latter should undergo surgical excision for histologic characterization (adenoma vs. carcinoma). In this study, we report the combined experience from our institutions with thyroid FNA cases that can be placed into NCI-designated thyroid FNA diagnostic categories for follicular patterned lesions.The case cohort comprised of 857 cases in 645 females and 212 males; 509 cases could be classified as FLUS/AUS and 348 as SFON/FON. Histologic follow-up was available in 273/509 (54%) cases diagnosed as FLUS/AUS and 251/348 (72%) cases diagnosed as SFON/FON.RFNA was performed in 203/509 (40%) patients classified as FLUS/AUS. RFNA diagnoses were: benign (125 cases), FLUS (46 cases), SFON/FON (20 cases), suspicious for papillary carcinoma (7 cases), papillary carcinoma (3 cases) and non-diagnostic (2 cases). The malignancy rate on surgical excision in the FLUS/AUS group was 27 and 15% with and without RFNA, respectively; and 25% in cases diagnosed as SFON/FON.RFNA is effective in managing thyroid nodules diagnosed as FLUS/AUS since the malignancy rates are different in cases with or without RFNA (27% vs. 15%). The malignancy rate (25%) in cases diagnosed as SFON/FON is similar to reported by other authors.
机译:美国国家癌症研究所(NCI)关于甲状腺细针穿刺(FNA)的科学会议状态建议,滤泡样病变可分为两个诊断类别:未确定意义的卵泡病变/未确定意义的异型性(FLUS / AUS),可疑为滤泡性肿瘤/滤泡性肿瘤(SFON / FON)。前者可通过重复FNA(RFNA)来获得更明确的诊断,而后者应进行手术切除以进行组织学表征(腺瘤与癌)。在这项研究中,我们报告了来自我们机构的甲状腺FNA病例的综合经验,这些经验可以纳入NCI指定的甲状腺FNA诊断类滤泡样病变中。病例队列由857例女性组成,其中645例女性和212例男性; 509个案例可以分类为FLUS / AUS,348个分类为SFON / FON。在273/509(54%)被诊断为FLUS / AUS的患者和251/348(72%)被诊断为SFON / FON的患者中进行组织学随访.RFNA在被分类为FLUS的203/509(40%)患者中进行/ AUS。 RFNA诊断为:良性(125例),FLUS(46例),SFON / FON(20例),可疑乳头状癌(7例),乳头状癌(3例)和非诊断性(2例)。有/无RFNA的FLUS / AUS组手术切除的恶性率分别为27%和15%。 RFNA可有效管理被诊断为FLUS / AUS的甲状腺结节,因为有或无RFNA的患者的恶性率均不同(27%比15%)。被诊断为SFON / FON的病例的恶性率(25%)与其他作者的报道相似。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号